Andrew Clews

Callaghan Innovation

Andrew is Callaghan Innovation’s Head of Health Technology and represents it as a constituent part of the Consortium for Medical Device Technologies (CMDT). As New Zealand’s innovation agency, Callaghan Innovation works with ambitious businesses of all sizes, delivering a range of innovation and research and development (R&D) services to suit each stage of their growth.

Andrew joined Callaghan Innovation following more than 16 years in the US working in complex sectors as diverse as electromechanical devices and biotech/cleantech. He has a background in business internationalisation and the commercialisation of new technology, new products and new brands in complex categories. Andrew has held senior management and leadership team roles in a wide variety of organisations from major corporates to startups and IPO-focused growth companies.